Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma

References

Page 1

	Year	Citations
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma Roger Stupp, Warren Mason, Martin J. van den Bent, New England Journal of Medicine	2005	21K
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Roger Stupp, Monika E. Hegi, Warren Mason, The Lancet Oncology 5-Year AnalysisNeuro-oncologyOncologyRadiation TherapyAdjuvant Temozolomide	2009	7.7K
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia, New England Journal of Medicine	2005	7.1K
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Patrick Y. Wen, David R. Macdonald, David A. Reardon, Journal of Clinical Oncology EngineeringHigh-grade GliomasBrain LesionResponse AssessmentGlioma	2010	3.7K
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, New England Journal of Medicine	2014	2.7K
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma Roger Stupp, Sophie Taillibert, Andrew A. Kanner, JAMA	2017	2.5K
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma Roger Stupp, Sophie Taillibert, Andrew A. Kanner, JAMA	2015	1.2K
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell, JNCI Journal of the National Cancer Institute Cancer ManagementEpidemiology Of CancerCancer RegistrationCancer EducationCancer Clinical Research	2014	1.1K
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors Eilon D. Kirson, Vladimír Dbalý, F Tovaryś, Proceedings of the National Academy of Sciences Tumor InnervationHigh-grade GliomasBiomedical EngineeringGliomaTumor Biology	2007	846
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality Roger Stupp, Eric T. Wong, Andrew A. Kanner, European Journal of Cancer	2012	828

Page 1